AG
BIIB icon

Ascent Group’s Biogen BIIB Stock Holding History

Ascent Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
6,836
+802
+13% +$148K 0.04% 326
2025
Q4 		$1.06M Buy
6,034
+2,086
+53% +$341K 0.04% 358
2025
Q3 		$553K Buy
3,948
+1,234
+45% +$167K 0.02% 476
2025
Q2 		$341K Buy
+2,714
New +$338K 0.01% 551

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascent Group's BIIB Position: Q1 2026 in Review

Ascent Group increased its Biogen (BIIB) stake by 13% in Q1 2026, buying an estimated $148K and bringing the position to 6,836 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #326.

Ascent Group first reported a position in BIIB in Q2 2025 and has held it in 4 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Ascent Group held 6,836 shares of Biogen worth $1.25M as of Q1 2026.
  • Ascent Group bought 802 Biogen shares in Q1 2026, an estimated $148K.
  • Biogen made up 0.04% of Ascent Group's portfolio in Q1 2026, its #326 holding.
  • Ascent Group first reported a position in Biogen in Q2 2025 and has held it in 4 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.